Por favor, use este identificador para citar o enlazar este ítem:
https://doi.org/10.3109/00365548.2012.752859


Título: | Cutaneous leishmaniasis in a patient receiving infliximab |
Editorial: | Taylor and Francis Group |
Cita bibliográfica: | Scandinavian Journal of Infectious Diseases, 2012; Early Online: 1–3 |
ISSN: | Print.: 2374-4235 Electronic.: 2374-4243 |
Palabras clave: | Leishmania Cutaneous Leishmaniasis Tumour necrosis factor antagonists Infliximab |
Resumen: | Abstract Leishmaniasis is endemic in the Mediterranean region, and the prevalence of latent infection in this area is high. Treatment with tumour necrosis factor (TNF) antagonists represents a major breakthrough in the treatment of several infl ammatory diseases, including psoriasis. Reports describing opportunistic leishmaniasis in European patients treated with TNF- α antagonist drugs are rapidly accumulating. We describe a case of cutaneous leishmaniasis in a patient treated with infl iximab and corticosteroids. |
Autor/es principal/es: | Hernández Torres, Alicia García Vázquez, Elisa Frías Iniesta, José Herrero Martínez, José Antonio Gómez Gómez, Joaquín |
Versión del editor: | https://www.tandfonline.com/doi/full/10.3109/00365548.2012.752859 |
URI: | http://hdl.handle.net/10201/149908 |
DOI: | https://doi.org/10.3109/00365548.2012.752859 |
Tipo de documento: | info:eu-repo/semantics/article |
Número páginas / Extensión: | 3 |
Derechos: | info:eu-repo/semantics/embargoedAccess |
Descripción: | © 2012 Informa Healthcar. This document is the published version of a published work that appeared in final form in Scandinavian Journal of Infectious Diseases. . To access the final edited and published work see: https://doi.org/10.3109/00365548.2012.752859 |
Aparece en las colecciones: | Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Articulo LC.pdf | 127,17 kB | Adobe PDF | ![]() Visualizar/Abrir Solicitar una copia |
Los ítems de Digitum están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.